Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Oct 7, 2022; 28(37): 5444-5456
Published online Oct 7, 2022. doi: 10.3748/wjg.v28.i37.5444
Table 4 Logistic regression analysis to evaluate the association between LFN-COVID-19 index and clinical outcomes
Orotracheal intubation
Acute kidney injury

OR
95%CI
B coefficient
P value
OR
95%CI
B coefficient
P value
LFN-COVID-19 index1.9001.481-2.4370.6420.0001.8491.366-2.5040.6150.000
Sex0.6050.288-1.271-0.5020.1850.2800.103-0.765-1.2720.013
Age0.9660.939-0.993-0.0350.0151.0210.988-1.0540.0210.209
BMI1.0540.997-1.1140.0530.0611.0851.011-1.1640.0810.023

  • Citation: Macías-Rodríguez RU, Solís-Ortega AA, Ornelas-Arroyo VJ, Ruiz-Margáin A, González-Huezo MS, Urdiales-Morán NA, Román-Calleja BM, Mayorquín-Aguilar JM, González-Regueiro JA, Campos-Murguía A, Toledo-Coronado IV, Chapa-Ibargüengoitia M, Valencia-Peña B, Martínez-Cabrera CF, Flores-García NC. Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19. World J Gastroenterol 2022; 28(37): 5444-5456
  • URL: https://www.wjgnet.com/1007-9327/full/v28/i37/5444.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v28.i37.5444